Xontogeny is a biotech aggregator.
Xontogeny seeks to accelerate the development of life science technologies by providing entrepreneurs with the leadership, strategic guidance and operational support necessary to increase the probability of success in early drug and technology development. Through a differentiated approach, the Xontogeny team partners with the founding scientists and entrepreneurs of new ventures to support their vision while allowing a more efficient development model to benefit company founders and early equity holders.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
May 18, 2017 | Series A | $15M | 1 |
![]() |
— | Detail |
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|
Dec 13, 2022
![]() |
Series A | $35M | Biotechnology | Yes |
Dec 13, 2022
![]() |
Series A | $25M | Biopharma | Yes |
Apr 11, 2022
![]() |
Seed | — | Health Care | Yes |
May 12, 2021
![]() |
Seed | — | Biopharma | Yes |
May 12, 2021
![]() |
Seed | — | Biopharma | Yes |
Investor Name | Lead Investor | Funding Round |
---|---|---|
![]() |
Yes | Series A |